VIR-2218, VIR-3434, HEPCLUDEX 2 mg powder for solution for injection
VIR-CHDV-V205
Phase 3 small_molecule active
Quick answer
VIR-2218, VIR-3434, HEPCLUDEX 2 mg powder for solution for injection for Chronic Hepatitis D Virus (HDV) Infection is a Phase 3 program (small_molecule) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vir Biotechnology
- Indication
- Chronic Hepatitis D Virus (HDV) Infection
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active